News
Acadia Healthcare Forms Joint Venture with Bronson Health to Build a New Behavioral Health Facility in Southwest Michigan
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Bronson Healthcare, one of Michigan’s leading, integrated healthcare systems. The new
QIAGEN geht Partnerschaft mit Verogen ein und bietet nun das umfassendste Portfolio an Produkten für die Personenidentifizierung, darunter NGS-Sequenzierungslösungen
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute eine Vermarktungspartnerschaft mit Verogen bekannt gegeben, einem in San Diego ansässigen Spezialisten für Forensik. Kunden beider
QIAGEN Partners with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a commercialization partnership with San Diego-based human identification specialist Verogen that will provide customers of
Charles River Laboratories Completes Acquisition of Vigene Biosciences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Vigene Biosciences, Inc. for $292.5 million in cash, subject
LivaNova to Host Conference Call for Second Quarter 2021 Results
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second quarter 2021 results on Wednesday, July 28, 2021 at 1 p.m
Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma
Regulatory News:
Abbas Hussain (56, British citizen) has a successful and international career of more than 30 years as an executive in the healthcare sector. From 2008 to 2017, Abbas Hussain
Abbas Hussain zum neuen Chief Executive Officer von Vifor Pharma ernannt
Regulatory News:
Abbas Hussain (56, britischer Staatsbürger) verfügt über eine mehr als 30-jährige erfolgreiche und internationale Karriere als Führungskraft im Gesundheitssektor. Von 2008 bis
Vifor Pharma to revise DIAMOND study, readout expected in H2 2021
Regulatory News:
Vifor Pharma Group today announced that the phase-IIIb DIAMOND study has been amended with new and clinically relevant endpoints, including a new primary endpoint of efficacy in
Staff Care Survey: Locum Tenens Physicians Play Active Role in Treating Covid-19 Patients
Close to three quarters (71%) of locum tenens physicians and other advanced practice healthcare professionals working on a temporary basis have treated Covid-19 patients, according to a new survey
Genus plc to Hold Capital Markets Event Today at 10:00 AM ET and Provide Update on its Porcine PRRSv Resistance Program
Genus plc (LSE: GNS), a leading global animal genetics company, is hosting a Capital Markets Event (CME) today at 10 AM ET, 3pm UK time. The CME will cover key strategic progress and initiatives
QIAGEN bringt dedizierte CRISPR-Produkte für schnelle und einfache Analyse der Auswirkungen von Genome Editing auf den Markt
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Einführung des QIAprep& CRISPR Kit und der CRISPR Q-Primer Solutions bekannt, die Forscher in die Lage versetzen, bearbeitetes
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with
AMN Highest Ranked Healthcare MSP in Global HRO Today Customer Satisfaction Awards
AMN Healthcare (NYSE: AMN), the leader and innovator in healthcare total talent services to facilities across the nation, achieved the highest ranking for a healthcare Managed Services Program in
ICON Announces Pricing of Senior Secured Notes
ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (“PRA”) pursuant to which Indigo Merger Sub, Inc., a wholly owned
Premier Inc. Honors Florida Nonprofit Dedicated to Fighting Food Insecurity With National Award and $100,000 Prize
Community Enhancement Collaboration, Inc. (CEC), a nonprofit dedicated to eradicating food insecurity in Broward County, Florida, has received the 28th annual Monroe E. Trout Premier Cares Award
Atrium Health Recognized for Innovation, High-Quality Healthcare by Premier Inc.
Premier Inc., a leading healthcare improvement company, (NASDAQ: PINC) has named Atrium Health, an integrated, nonprofit health system serving the Carolinas and Georgia, the winner of the 2021
Novocure Initiates Usability Study for Flexible Torso Array
Novocure (NASDAQ: NVCR) today announced it has advanced a new, flexible torso array into a clinical usability study. The updated array will be tested by patients and their caregivers at four
ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting
ICON plc (NASDAQ: ICLR) (“ICON”), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and
LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to proceed with its
ICON Announces Private Offering of Senior Secured Notes
ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (“PRA”) pursuant to which Indigo Merger Sub, Inc., a wholly owned
Charles River Laboratories Announces Long-Term Solar Contract for North American Operations
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a long-term solar energy contract to address the entirety of the Company’s North American electric power requirements with
LivaNova vollzieht den initialen Verkaufsabschluss des Herzklappengeschäfts an Gyrus Capital
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen im Bereich Medizintechnik und Innovation, gab heute bekannt, dass es den initialen Abschluss der Veräußerung seines Herzklappengeschäfts
LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has successfully completed the initial closing of the divestiture of its heart valve (HV)
QIAGEN stellt erstes von der FDA zugelassenes gewebebasiertes Begleitdiagnostikum zur Identifizierung von NSCLC-Patienten mit der KRAS-G12C-Mutation bereit und erweitert damit die Möglichkeiten der Präzisionsmedizin im Bereich Lungenkrebs
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass die Zulassung für das Begleitdiagnostikum therascreen® KRAS RGQ PCR Kit (therascreen KRAS Kit) erweitert wurde. Das
QIAGEN Launches First FDA-approved Tissue Companion Diagnostic to Identify the KRAS G12C Mutation in NSCLC Tumours and Expand Precision Medicine Options in Lung Cancer
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of an expanded scope of companion diagnostic (CDx) claims for the therascreen® KRAS RGQ PCR Kit (therascreen KRAS